Deutsche Bank
ADVM

Deutsche Bank’s Adverum Biotechnologies ADVM Stock Holding History

Deutsche Bank’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1
Closed -$5 – 3622
2025
Q3 		$5 Hold
1
– – ﹤0.01% 3598
2025
Q2 		$2 Hold
1
– – ﹤0.01% 3600
2025
Q1 		$4 Hold
1
– – ﹤0.01% 3591
2024
Q4 		$5 Hold
1
– – ﹤0.01% 3597
2024
Q3 		$7 Sell
1
-1
-50% -$7 ﹤0.01% 3599
2024
Q2 		$14 Hold
2
– – ﹤0.01% 3550
2024
Q1 		$28 Hold
2
– – ﹤0.01% 3607
2023
Q4 		$14 Buy
+2
New +$18 ﹤0.01% 3623
2023
Q3 		– Sell
-2
Closed -$29 – 3698
2023
Q2 		$29 Hold
2
– – ﹤0.01% 3790
2023
Q1 		$13 Hold
2
– – ﹤0.01% 3901
2022
Q4 		$10 Hold
2
– – ﹤0.01% 4005
2022
Q3 		$0 Hold
2
– – ﹤0.01% 3969
2022
Q2 		$0 Sell
2
-4,716
-100% -$49.4K ﹤0.01% 4120
2022
Q1 		$62K Sell
4,718
-560
-11% -$8.19K ﹤0.01% 3762
2021
Q4 		$93K Buy
5,278
+279
+6% +$5.58K ﹤0.01% 3741
2021
Q3 		$108K Sell
4,999
-48,294
-91% -$1.23M ﹤0.01% 3873
2021
Q2 		$1.87M Buy
53,293
+46,052
+636% +$2.48M ﹤0.01% 2294
2021
Q1 		$713K Sell
7,241
-1,681
-19% -$202K ﹤0.01% 2870
2020
Q4 		$967K Sell
8,922
-95,160
-91% -$11.8M ﹤0.01% 2466
2020
Q3 		$10.7M Buy
104,082
+99,757
+2,307% +$14.9M 0.01% 941
2020
Q2 		$903K Sell
4,325
-6,157
-59% -$1.09M ﹤0.01% 2292
2020
Q1 		$1.02M Sell
10,482
-11,495
-52% -$1.34M ﹤0.01% 2070
2019
Q4 		$2.53M Buy
21,977
+13,380
+156% +$1.18M ﹤0.01% 1824
2019
Q3 		$467K Buy
8,597
+5,246
+157% +$591K ﹤0.01% 2709
2019
Q2 		$397K Sell
3,351
-3,318
-50% -$275K ﹤0.01% 3428
2019
Q1 		$347K Sell
6,669
-5,380
-45% -$217K ﹤0.01% 3669
2018
Q4 		$379K Sell
12,049
-7,674
-39% -$312K ﹤0.01% 3510
2018
Q3 		$1.19M Sell
19,723
-13,201
-40% -$741K ﹤0.01% 3199
2018
Q2 		$1.74M Buy
32,924
+7,130
+28% +$429K ﹤0.01% 3052
2018
Q1 		$1.5M Sell
25,794
-12,539
-33% -$781K ﹤0.01% 3063
2017
Q4 		$1.34M Buy
38,333
+19,688
+106% +$648K ﹤0.01% 3004
2017
Q3 		$680K Buy
18,645
+8,761
+89% +$243K ﹤0.01% 3248
2017
Q2 		$246K Sell
9,884
-2,850
-22% -$77.9K ﹤0.01% 3811
2017
Q1 		$341K Buy
12,734
+2,082
+20% +$59.2K ﹤0.01% 3301
2016
Q4 		$307K Sell
10,652
-15,302
-59% -$500K ﹤0.01% 3452
2016
Q3 		$1.06M Buy
25,954
+433
+2% +$16.4K ﹤0.01% 2787
2016
Q2 		$806K Buy
25,521
+18,791
+279% +$849K ﹤0.01% 3032
2016
Q1 		$347K Buy
6,730
+6,238
+1,268% +$348K ﹤0.01% 3398
2015
Q4 		$45K Sell
492
-376
-43% -$33K ﹤0.01% 4443
2015
Q3 		$71K Sell
868
-4,655
-84% -$595K ﹤0.01% 4259
2015
Q2 		$897K Buy
5,523
+4,078
+282% +$1.38M ﹤0.01% 3035
2015
Q1 		$584K Buy
1,445
+11
+0.8% +$4.65K ﹤0.01% 3212
2014
Q4 		$772K Buy
1,434
+480
+50% +$185K ﹤0.01% 3378
2014
Q3 		$326K Buy
+954
New +$284K ﹤0.01% 3767

Deutsche Bank's ADVM Position: Q4 2025 in Review

Deutsche Bank sold out of Adverum Biotechnologies (ADVM) in Q4 2025, closing a stake of 1 share — an estimated $5 sold.

Deutsche Bank first reported a position in ADVM in Q3 2014 and held it in 44 quarters. The position peaked at $10.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold ADVM as of Q4 2025.

  • Deutsche Bank reported no remaining Adverum Biotechnologies position as of Q4 2025 after selling out during the quarter.
  • Deutsche Bank sold 1 Adverum Biotechnologies share in Q4 2025, an estimated $5.
  • Deutsche Bank first reported a position in Adverum Biotechnologies in Q3 2014 and held it in 44 quarters.
  • Deutsche Bank's Adverum Biotechnologies position peaked at $10.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2025.

Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.